AI assistant
Lunai Bioworks Inc. — Director's Dealing 2022
Jul 18, 2022
34813_dirs_2022-07-18_73f2b508-4f31-4aec-9f73-058fb262a23c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2022-06-08
Reporting Person: Sindlev Rene (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-08 | Common Stock | J | 125000 | — | Disposed | 0 | Indirect |
| 2022-06-08 | Common Stock | J | 128493 | — | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9668351 | Indirect |
Footnotes
F1: On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid.
F2: On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.